Cargando…

The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study

AIMS: Despite evidence‐based therapeutic approaches, target blood pressure is obtained by less than half of patients with hypertension. Hypertension is associated with a significant risk for heart failure, in particular heart failure with preserved left ventricular (LV) ejection fraction (HFpEF). Al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ekström, Mattias, Hellman, Anna, Hasselström, Jan, Hage, Camilla, Kahan, Thomas, Ugander, Martin, Wallén, Håkan, Persson, Hans, Linde, Cecilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Study Designs
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160482/ https://www.ncbi.nlm.nih.gov/pubmed/32073753 http://dx.doi.org/10.1002/ehf2.12612

Ejemplares similares

Baseline characteristics of 547 new onset heart failure patients in the PREFERS heart failure study
por: Linde, Cecilia, et al.
Publicado: (2022)

Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting
por: Matan, Dmitri, et al.
Publicado: (2022)

Cohort profile: The PreEclampsia, Angiogenesis, Cardiac dysfunction and Hypertension (PEACH) Study
por: Persson, Lisa Kristine Grange, et al.
Publicado: (2022)

Hypertensive Heart Failure
por: Triposkiadis, Filippos, et al.
Publicado: (2023)

PRADOC: a trial on the efficiency of a transition care management plan for hospitalized patients with heart failure in France
por: Duflos, Claire, et al.
Publicado: (2020)

The genomics of heart failure: design and rationale of the HERMES consortium
por: Lumbers, R. Thomas, et al.
Publicado: (2021)

Impact of B‐lines‐guided intensive heart failure management on outcome of discharged heart failure patients with residual B‐lines
por: Zhu, Yunlong, et al.
Publicado: (2022)

Pulmonary Hypertension in Heart Failure
por: Jang, Albert Youngwoo, et al.
Publicado: (2021)

Catheter ablation for atrial fibrillation in patients with end‐stage heart failure and eligibility for heart transplantation
por: Sohns, Christian, et al.
Publicado: (2020)

The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)
por: Wiggers, Henrik, et al.
Publicado: (2021)

Kyoto Congestive Heart Failure (KCHF) study: rationale and design
por: Yamamoto, Erika, et al.
Publicado: (2017)

PRecision Event Monitoring for PatienTs with Heart Failure using HeartLogic (PREEMPT‐HF) study design and enrolment
por: Boehmer, John, et al.
Publicado: (2023)

Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial
por: ter Maaten, Jozine M., et al.
Publicado: (2022)

Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2018)

Role of Kinins in Hypertension and Heart Failure
por: Hamid, Suhail, et al.
Publicado: (2020)

Pulmonary Hypertension in Heart Failure Patients
por: Rao, Sriram D, et al.
Publicado: (2020)

A remote hypertension management program clinical algorithm
por: Nichols, Hunter, et al.
Publicado: (2022)

Management of heart failure with reduced ejection fraction in Europe: design of the ARIADNE registry
por: Zeymer, Uwe, et al.
Publicado: (2020)

Heart failure prevalence in the general population: SOBOTA‐HF study rationale and design
por: Lainscak, Mitja, et al.
Publicado: (2019)

Regional management of worsening heart failure: rationale and design of the CHAIN‐HF registry
por: Shakoor, Abdul, et al.
Publicado: (2023)

Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN‐HF study
por: Correale, Michele, et al.
Publicado: (2023)

Targets and management of hypertension in heart failure: focusing on the stages of heart failure
por: Miao, Huanhuan, et al.
Publicado: (2022)

Effect of melatonin on heart failure: design for a double‐blinded randomized clinical trial
por: Sadeghi, Masoumeh, et al.
Publicado: (2020)

Rationale and design of the EPCHF trial: the early palliative care in heart failure trial (EPCHF)
por: Becher, Marc Ulrich, et al.
Publicado: (2021)

Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study
por: Dauw, Jeroen, et al.
Publicado: (2021)

Utilizing longitudinal data in assessing all‐cause mortality in patients hospitalized with heart failure
por: Herman, Robert, et al.
Publicado: (2022)

Radiological Appearances of the Heart and Lungs in Cases of Hypertensive Heart Failure
por: Vakil, Rustom J.
Publicado: (1940)

Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol
por: Chow, Clara K., et al.
Publicado: (2021)

Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR‐AHF
por: Palazzuoli, Alberto, et al.
Publicado: (2017)

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post‐discharge period
por: Pölzl, Gerhard, et al.
Publicado: (2018)

Rationale and design of the EMPERIAL‐Preserved and EMPERIAL‐Reduced trials of empagliflozin in patients with chronic heart failure
por: Abraham, William T., et al.
Publicado: (2019)

Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS)
por: Yun, Sergi, et al.
Publicado: (2020)

Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial
por: Solomon, Scott D., et al.
Publicado: (2021)

Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
por: Hundertmark, Moritz J., et al.
Publicado: (2021)

Rationale and design of the AMULET study: A new Model of telemedical care in patients with heart failure
por: Krzesiński, Paweł, et al.
Publicado: (2021)

Rationale and Study Design of the Withdrawal of Spironolactone for Heart Failure with Improved Left Ventricular Ejection Fraction
por: Hyun, Junho, et al.
Publicado: (2021)

Daprodustat for anaemia in patients with heart failure and chronic kidney disease: A randomized controlled study
por: Iso, Takashi, et al.
Publicado: (2022)

Conduction system pacing and atrioventricular node ablation in heart failure: The PACE‐FIB study design
por: Rodríguez Muñoz, Daniel, et al.
Publicado: (2023)

Left ventricular heart failure and pulmonary hypertension(†)
por: Rosenkranz, Stephan, et al.
Publicado: (2016)

Pulmonary Hypertension and Cardiopulmonary Exercise in Heart Failure
por: Kim, Chul-Ho, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_54r95trldfas34i38e17ee2pms